Author
Listed:
- S. Brian Wilson
(Harvard University)
- Sally C. Kent
(Center for Neurologic Diseases, Brigham and Women's Hospital, Brigham and Women's Hospital Harvard Medical School)
- Kurt T. Patton
(Center for Neurologic Diseases, Brigham and Women's Hospital, Brigham and Women's Hospital Harvard Medical School)
- Tihamer Orban
(Immunology Section, Joslin Diabetes Center, Brigham and Women's Hospital Harvard Medical School)
- Richard A. Jackson
(Immunology Section, Joslin Diabetes Center, Brigham and Women's Hospital Harvard Medical School)
- Mark Exley
(Cancer Biology Program, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital Harvard Medical School)
- Steven Porcelli
(Lymphocyte Biology Section, Immunology and Allergy, Brigham and Women's Hospital Harvard Medical School)
- Desmond A. Schatz
(University of Florida)
- Mark A. Atkinson
(University of Florida)
- Steven P. Balk
(Cancer Biology Program, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital Harvard Medical School)
- Jack L. Strominger
(Harvard University)
- David A. Hafler
(Center for Neurologic Diseases, Brigham and Women's Hospital, Brigham and Women's Hospital Harvard Medical School)
Abstract
Type 1 diabetes (insulin-dependent diabetes mellitus, IDDM) is a disease controlled by the major histocompatibility complex (MHC) which results from T-cell-mediated destruction of pancreatic β-cells1. The incomplete concordance in identical twins and the presence of autoreactive T cells and autoantibodies in individuals who do not develop diabetes suggest that other abnormalities must occur in the immune system for disease to result2,3. We therefore investigated a series of at-risk non-progressors and type1 diabetic patients (including five identical twin/triplet sets discordant for disease). The diabetic siblings had lower frequencies of CD4−CD8− Vα24JαQ+ T cells compared with their non-diabetic sibling. All 56 Vα24JαQ+ clones isolated from the diabetic twins/triplets secreted only interferon (IFN)-γ upon stimulation; in contrast, 76 of 79 clones from the at-risk non-progressors and normals secreted both interleukin (IL)-4 and IFN-γ. Half of the at-risk non-progressors had high serum levels of IL-4 and IFN-γ. These results support a model for IDDM in which Th1-cell-mediated tissue damage is initially regulated by Vα24JαQ+ T cells producing both cytokines; the loss of their capacity to secrete IL-4 is correlated with IDDM.
Suggested Citation
S. Brian Wilson & Sally C. Kent & Kurt T. Patton & Tihamer Orban & Richard A. Jackson & Mark Exley & Steven Porcelli & Desmond A. Schatz & Mark A. Atkinson & Steven P. Balk & Jack L. Strominger & Davi, 1998.
"Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes,"
Nature, Nature, vol. 391(6663), pages 177-181, January.
Handle:
RePEc:nat:nature:v:391:y:1998:i:6663:d:10.1038_34419
DOI: 10.1038/34419
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:391:y:1998:i:6663:d:10.1038_34419. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.